NCT04644419View on ClinicalTrials.gov

Chemotherapy-related Cognitive Impairment and Acute Leukemia

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

October 15, 2022

Study Completion Date

May 3, 2023

Conditions
Acute Myeloid Leukemia
Interventions
OTHER

none (observational study)

This is an observational study and does not include intervention delivery.

Trial Locations (1)

27599

University of North Carolina Lineberger Comprehenisive Cancer Center, Chapel Hill

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT04644419 - Chemotherapy-related Cognitive Impairment and Acute Leukemia | Biotech Hunter | Biotech Hunter